Structural Biology and Molecular Modeling Market

Structural Biology and Molecular Modeling Market Size by Tools (SaaS& standalone modeling, Visualization & analysis, Databases), Application (Drug development, Drug discovery), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2021 to 2028

Base Year: 2020 Historical Data: 2018-19
  • Report ID: TBI-12549
  • Published Date: Oct, 2021
  • Pages: 249
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

Global structural biology and molecular modeling market is expected to reach USD 21.26 Billion by 2028, at a CAGR of 13.56% from 2021 to 2028. Global Structural Biology and Molecular Modeling market is witnessing a considerable growth owing to the increasing occurrence of chronic diseases.

Market Overview:

Structural biology studies about the molecular structure of biological macromolecules like proteins and nucleic acids this gives the key insight of biological reactions which fuels life. Scientist use the imaging technology to see the 3d view of the molecules to study its functionalities and interactions. The structural biologist didn’t get to see the image of the biomolecules because the technology is not that advanced, so they have to work on the measurement of many similar kind of molecules to get the structure. The advancement in technologies, use of virtual reality and software can transform this drug discovery field. Structural biologists mostly focuses on the protein because of their central role in the body. They study the functionality of the molecules and how they reacts to give a new life.  Molecular modelling is the methodology to analyze the 3d structure of the biological macromolecules. All the drug designing companies are focusing on the modelling projects to understand the structure of newly made drugs so that they can go for biding. The unhealthy lifestyle of the people these days are leading to increase the cases of chronic disease. Also, the increase in the geriatric population in the developed countries are also increasing the cases of chronic diseases like diabetes, cancer etc. This structural biology and molecular modelling is very useful in medicinal and healthcare sector as it helps in finding the remedies for several diseases. Therefore the increasing cases of chronic diseases because of an unhealthy lifestyle is the factor that drives this market. Also, the increase in investment in R&D by the pharmaceuticals company would drive this market as this can come up with fruitful discovery, that could give solution to many incurable disease. Also the outbreak of a new disease like Ebola and coronavirus etc. would also drive this market in the future. The structural biology and molecular modeling is essential for the medicinal and pharmaceuticals firm to come up with better solutions for the illness.

Get an overview of this study by requesting a free sample

Market Dynamics:

Drivers:

  • Increasing occurrence of chronic diseases

The unhealthy lifestyle of the people these days are leading to increasing cases of chronic disease and also the increase in geriatric population in the developed countries are also increasing the cases of chronic diseases like diabetes, cancer, heart disease etc. This structural biology and molecular modelling is very useful in medicinal and healthcare sector as it helps in finding the remedies for several diseases. Therefore the increasing cases of chronic diseases because of an unhealthy lifestyle is the factor that drives this market. Also, the increase in investment in R&D by the pharmaceuticals company would drive this market as this can come up with fruitful discovery, that could give solution to many incurable disease.

  • Increasing geriatric population

The increase in geriatric population in the developed countries are contributing to the increasing cases of chronic diseases like diabetes, cancer, heart disease etc. The structural biology and molecular modelling is helpful in medicinal and healthcare sector as it helps in finding the remedies for several diseases.

Restraints:

  • Strict regulation by government and availability of alternatives

Thou the government is working hard and encouraging the research and pharmaceuticals company to improve the quality of medicines, but also they are imposing stringent regulation to control the research and pharmaceuticals company, to make them follow the guidelines so that in improving and coming up with the better quality and outcome they do not hamper other things. Like for R & D companies, the standard the companies should follow for the betterment of their employees. Also, for the pharmaceuticals company, the rules are the same. The availability of alternatives which are cheaper also could hamper or restrain this market.

Opportunities:

  • Improving the quality of medicine and healthcare

The technological advancement, use of virtual reality and software can improve the quality of medicine and healthcare. Structural biologists mostly focuses on the protein because of their central role in the body. They study the functionality of the molecules and the reaction they do to give a new life.  Molecular modelling is the methodology to analyze the 3d structure of the biological macromolecules. All the drug designing companies are focusing on the modelling projects to understand the structure of newly made drugs.

Segmentation Analysis:

The global Structural Biology and Molecular Modeling market has been segmented based on tools, application and regions.

  • Tools segment include SaaS& standalone modeling, visualization & analysis, databases and others. The SaaS& standalone modeling segment held the substantial market share of over 40.35% in 2020. This is due to the fact that increasing use of software to study and analyze the structure of the molecules to see the reaction etc. Also, the computer-aided predictive procedure in structural biology would also propel this market.
  • The application segment includes drug discovery, drug development and others. Drug development segment accounted for the largest market share in 2020 of around 48.74%. This owes to the increasing outbreak of new diseases across the globe and also the R&D companies does to come up with a new drug, to cure the disease.

Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa.North Americais accounted for the highest market share of around  36.78% in 2020.

  • North America region is the leading segment because it has the most advanced and better infrastructure. Also, this region is the belt where a big pharmaceuticals company lies who are investing in R&D to come up with a better solution to cure the illness. This would drive the structural biology and molecular modelling market. Also, the big players are collaborating among themselves to heighten the R & D capabilities to come up with a better solution for the diseases will drive this market in this region.
  • Asia Pacific is anticipated to have the exponential CAGR as the government in the developing countries of this region gives favourable initiatives to the pharmaceutical companies for the R&D.

The North America Structural Biology and Molecular Modeling Market Share in 2020 - 36.78%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Competitive Analysis:

The key players are now concentrating on implementing strategies such as adopting new technology, product innovations, mergers & acquisitions, joint venture, alliances and partnerships to improve their market position in the global structural biology and molecular modeling industry.

For instance, in December 2019, Roche did merger agreement with Spark Therapeutics Inc. This merger agreement had strengthen the company’s presence in the field of gene therapy.

List of Key Market Players:

  • AlDassaultSystemes
  • Agile Molecule
  • Accellera Ltd.
  • Bioinformatic LLC
  • Affymetrix
  • Agilent Technologies, Inc.
  • Illumina
  • BrukerDaltonics Inc.
  • Biomax Informatics AG
  • Chemical Computing Group,
  • CLC bio
  • Roche

Key Target Audience

  • Drugs and Pharmaceutical Organization
  • Government Authorities
  • Research Organization

Report Description:

  • Global Market, Industry Analysis, Trends, Analysis and Forecast, 2021 to 2028 is a forthcoming/imminent research report which is to be published by The Brainy Insights.
  • 2020 is considered as the base year of the report. 2018 and 2019 are considered as the historic years and 2021 to 2028 are the forecast years. The global Structural Biology and Molecular Modeling market is based on revenue (USD Million/Billion), volume and price. The report incorporates the market study on the basis of revenue, and volume. The study covers the market share revenue/market share/volume for each of the segments, regions and countries catering to global Structural Biology and Molecular Modeling market. The regions analyzed for the market are Europe, Asia Pacific, North America, South America and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
  • The report encompasses with the relative data & information, which have been validated by the leading industry professionals and experts all across the globe. The research report also delivers an outline of the attractiveness of tools, application and regions which are deduced and formulated on the basis of their growth rate (CAGR), market size, and attractiveness by analyzing the present and future prospects to fathom market growth and development in future.
  • The report illustrates the detailed (both quantitative and qualitative) analysis of historical data, revenues, key developments, along with the crucial strategies adopted by key organizations catering to global Structural Biology and Molecular Modeling market.  This offers vital and in depth insights in order to depict the overall market scenario.
  • The report offers the detailed study for the company profiles of key organizations operating in the global Structural Biology and Molecular Modeling market and a comparative assessment based on their product offering, business overviews, geographic presence, business strategies, segment market share, product development & innovations, recent developments, joint venture, partnerships, mergers & acquisitions, strategic alliances, SWOT analysis, and key financial information. This helps in evaluating the overall competition present in the market scenario. 
  • The report provides an elaborative assessment of the porter’s five forces analysis coupled with SWOT analysis so as to provide business related data and information’s. Porter’s five forces model is analyzed to understand the overall competitive scenario that is prevailing in the market. Additionally, the SWOT analysis identifies both the positive and negative attributes of the market development which influences the company growth and development in order to sustain and survive in the long run.
  • Along with that, the report also focuses on the market related driving factors, growth limitations (restraints), potential industry opportunities, significant trends and development which acts as a key potential for the investors. 
  • Potential growth prospects along with the penetration rate analysis of the products (market related i.e., global Structural Biology and Molecular Modeling market) is covered in order to comprehend the adoption rate and evaluate the market size. 

Frequesntly Asked Questions

As per The Brainy Insights, the size of the structural biology and molecular modelling market was valued at USD 6.11 billion in 2020 and is anticipated to reach USD 21.26 billion by 2028.

Global structural biology and molecular modelling market is growing at a CAGR of 13.56% during the forecast period 2021-2028.

The global structural biology and molecular modeling market has been segmented based on tools, application and regions. The saas & standalone modeling segment held the substantial market share in 2020.

The North America region emerged as the largest market for the structural biology and molecular modeling.

Increasing occurrence of chronic diseases is the key driving factor for the structural biology and molecular modelling market.

Stringent regulation by government and availability of alternatives may hamper the market growth.

Improving the quality of medicine and healthcare will provide huge opportunities to the market.

Key players are AlDassaultSystemes, Agile Molecule, Accellera Ltd., Bioinformatic LLC, Affymetrix, Agilent Technologies, Inc., Illumina.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis By Tools
          4.3.2. Market Attractiveness Analysis By Application
          4.3.3. Market Attractiveness Analysis By Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Increasing occurrence of chronic diseases
          5.2.2. Increasing geriatric population
    5.3. Restrains
          5.3.1. Stringent regulation by government and availability of alternatives
    5.4. Opportunities
          5.4.1. Improving the quality of medicine and healthcare

6. Global Structural Biology and Molecular Modeling Market Analysis and Forecast, By Tools
    6.1. Segment Overview
    6.2. SaaS & standalone modelling
          6.2.1. Homology modeling
          6.2.2. Threading
          6.2.3. Molecular dynamics
          6.2.4. Ab Initio
          6.2.5. Hybrid
          6.2.6. Others
    6.3. Visualization & analysis
    6.4. Databases
    6.5. Others

7. Global Structural Biology and Molecular Modeling Market Analysis and Forecast, By Application
    7.1. Segment Overview
    7.2. Drug development
    7.3. Drug discovery
    7.4. Others

8. Global Structural Biology and Molecular Modeling Market Analysis and Forecast, By Regional Analysis
    8.1. Segment Overview
    8.2. North America
          8.2.1. U.S.
          8.2.2. Canada
          8.2.3. Mexico
    8.3. Europe
          8.3.1. Germany
          8.3.2. France
          8.3.3. U.K.
          8.3.4. Italy
          8.3.5. Spain
    8.4. Asia-Pacific
          8.4.1. Japan
          8.4.2. China
          8.4.3. India
    8.5. South America
          8.5.1. Brazil
    8.6. Middle East and Africa
          8.6.1. UAE
          8.6.2. South Africa

9. Global Structural Biology and Molecular Modeling Market-Competitive Landscape
    9.1. Overview
    9.2. Market Share of Key Players in GlobalStructural Biology and Molecular Modeling Market
          9.2.1. Global Company Market Share
          9.2.2. North America Company Market Share
          9.2.3. Europe Company Market Share
          9.2.4. APAC Company Market Share
    9.3. Competitive Situations and Trends
          9.3.1. Product Launches and Developments
          9.3.2. Partnerships, Collaborations, and Agreements
          9.3.3. Mergers & Acquisitions
          9.3.4. Expansions

10. Company Profiles
    10.1. AlDassault Systemes
          10.1.1. Business Overview
          10.1.2. Company Snapshot
          10.1.3. Company Market Share Analysis
          10.1.4. Company Product Portfolio
          10.1.5. Recent Developments
          10.1.6. SWOT Analysis
    10.2. Agile Molecule
          10.2.1. Business Overview
          10.2.2. Company Snapshot
          10.2.3. Company Market Share Analysis
          10.2.4. Company Product Portfolio
          10.2.5. Recent Developments
          10.2.6. SWOT Analysis
    10.3. Accellera Ltd.
          10.3.1. Business Overview
          10.3.2. Company Snapshot
          10.3.3. Company Market Share Analysis
          10.3.4. Company Product Portfolio
          10.3.5. Recent Developments
          10.3.6. SWOT Analysis
    10.4. Bioinformatic LLC
          10.4.1. Business Overview
          10.4.2. Company Snapshot
          10.4.3. Company Market Share Analysis
          10.4.4. Company Product Portfolio
          10.4.5. Recent Developments
          10.4.6. SWOT Analysis
    10.5. Affymetrix
          10.5.1. Business Overview
          10.5.2. Company Snapshot
          10.5.3. Company Market Share Analysis
          10.5.4. Company Product Portfolio
          10.5.5. Recent Developments
          10.5.6. SWOT Analysis
    10.6. Agilent Technologies, Inc.
          10.6.1. Business Overview
          10.6.2. Company Snapshot
          10.6.3. Company Market Share Analysis
          10.6.4. Company Product Portfolio
          10.6.5. Recent Developments
          10.6.6. SWOT Analysis
    10.7. Illumina
          10.7.1. Business Overview
          10.7.2. Company Snapshot
          10.7.3. Company Market Share Analysis
          10.7.4. Company Product Portfolio
          10.7.5. Recent Developments
          10.7.6. SWOT Analysis
    10.8. Bruker Daltonics Inc.
          10.8.1. Business Overview
          10.8.2. Company Snapshot
          10.8.3. Company Market Share Analysis
          10.8.4. Company Product Portfolio
          10.8.5. Recent Developments
          10.8.6. SWOT Analysis
    10.9. Biomax Informatics AG
          10.9.1. Business Overview
          10.9.2. Company Snapshot
          10.9.3. Company Market Share Analysis
          10.9.4. Company Product Portfolio
          10.9.5. Recent Developments
          10.9.6. SWOT Analysis
    10.10. Chemical Computing Group
          10.10.1. Business Overview
          10.10.2. Company Snapshot
          10.10.3. Company Market Share Analysis
          10.10.4. Company Product Portfolio
          10.10.5. Recent Developments
          10.10.6. SWOT Analysis
    10.11. CLC bio
          10.11.1. Business Overview
          10.11.2. Company Snapshot
          10.11.3. Company Market Share Analysis
          10.11.4. Company Product Portfolio
          10.11.5. Recent Developments
          10.11.6. SWOT Analysis
    10.12. Roche
          10.12.1. Business Overview
          10.12.2. Company Snapshot
          10.12.3. Company Market Share Analysis
          10.12.4. Company Product Portfolio
          10.12.5. Recent Developments
          10.12.6. SWOT Analysis
 

List of Table

1. Global Structural Biology and Molecular Modeling Market, By Tools, 2018-2028 (USD Billion)

2. Global SaaS & standalone modeling, Structural Biology and Molecular Modeling Market, By Region, 2018-2028 (USD Billion)

3. Global Visualization & analysis, Structural Biology and Molecular Modeling Market, By Region, 2018-2028 (USD Billion)

4. Global Databases, Structural Biology and Molecular Modeling Market, By Region, 2018-2028 (USD Billion)

5. Global Others, Structural Biology and Molecular Modeling Market, By Region, 2018-2028 (USD Billion)

6. Global Structural Biology and Molecular Modeling Market, By Application, 2018-2028 (USD Billion)

7. Global Drug developmentStructural Biology and Molecular Modeling Market, By Region, 2018-2028 (USD Billion)

8. Global Drug discovery, Structural Biology and Molecular Modeling Market, By Region, 2018-2028 (USD Billion)

9. Global Others, Structural Biology and Molecular Modeling Market, By Region, 2018-2028 (USD Billion)

10. Global Structural Biology and Molecular Modeling Market, By Region, 2018-2028 (USD Billion)

11. Global Structural Biology and Molecular Modeling Market, By North America, 2018-2028 (USD Billion)

12. North America Structural Biology and Molecular Modeling Market, By Tools, 2018-2028 (USD Billion)

13. North America Structural Biology and Molecular Modeling Market, By Application, 2018-2028 (USD Billion)

14. U.S. Structural Biology and Molecular Modeling Market, By Tools, 2018-2028 (USD Billion)

15. U.S. Structural Biology and Molecular Modeling Market, By Application, 2018-2028 (USD Billion)

16. Canada Structural Biology and Molecular Modeling Market, By Tools, 2018-2028 (USD Billion)

17. Canada Structural Biology and Molecular Modeling Market, By Application, 2018-2028 (USD Billion)

18. Mexico Structural Biology and Molecular Modeling Market, By Tools, 2018-2028 (USD Billion)

19. Mexico Structural Biology and Molecular Modeling Market, By Application, 2018-2028 (USD Billion)

20. Europe Structural Biology and Molecular Modeling Market, By Tools, 2018-2028 (USD Billion)

21. Europe Structural Biology and Molecular Modeling Market, By Application, 2018-2028 (USD Billion)

22. Germany Structural Biology and Molecular Modeling Market, By Tools, 2018-2028 (USD Billion)

23. Germany Structural Biology and Molecular Modeling Market, By Application, 2018-2028 (USD Billion)

24. France Structural Biology and Molecular Modeling Market, By Tools, 2018-2028 (USD Billion)

25. France Structural Biology and Molecular Modeling Market, By Application, 2018-2028 (USD Billion)

26. U.K. Structural Biology and Molecular Modeling Market, By Tools, 2018-2028 (USD Billion)

27. U.K. Structural Biology and Molecular Modeling Market, By Application, 2018-2028 (USD Billion)

28. Italy Structural Biology and Molecular Modeling Market, By Tools, 2018-2028 (USD Billion)

29. Italy Structural Biology and Molecular Modeling Market, By Application, 2018-2028 (USD Billion)

30. Spain Structural Biology and Molecular Modeling Market, By Tools, 2018-2028 (USD Billion)

31. Spain Structural Biology and Molecular Modeling Market, By Application, 2018-2028     (USD Billion)

32. Asia Pacific Structural Biology and Molecular Modeling Market, By Tools, 2018-2028      (USD Billion)

33. Asia Pacific Structural Biology and Molecular Modeling Market, By Application, 2018-2028 (USD Billion)

34. Japan Structural Biology and Molecular Modeling Market, By Tools, 2018-2028 (USD Billion)

35. Japan Structural Biology and Molecular Modeling Market, By Application, 2018-2028 (USD Billion)

36. China Structural Biology and Molecular Modeling Market, By Tools, 2018-2028 (USD Billion)

37. China Structural Biology and Molecular Modeling Market, By Application, 2018-2028 (USD Billion)

38. India Structural Biology and Molecular Modeling Market, By Tools, 2018-2028 (USD Billion)

39. India Structural Biology and Molecular Modeling Market, By Application, 2018-2028    (USD Billion)

40. South America Structural Biology and Molecular Modeling Market, By Tools, 2018-2028     (USD Billion)

41. South America Structural Biology and Molecular Modeling Market, By Application, 2018-2028 (USD Billion)

42. Brazil Structural Biology and Molecular Modeling Market, By Tools, 2018-2028 (USD Billion)

43. Brazil Structural Biology and Molecular Modeling Market, By Application, 2018-2028 (USD Billion)

44. Middle East and Africa Structural Biology and Molecular Modeling Market, By Tools, 2018-2028 (USD Billion)

45. Middle East and Africa Structural Biology and Molecular Modeling Market, By Application, 2018-2028 (USD Billion)

46. UAE Structural Biology and Molecular Modeling Market, By Tools, 2018-2028 (USD Billion)

47. UAE Structural Biology and Molecular Modeling Market, By Application, 2018-2028 (USD Billion)

48. South Africa Structural Biology and Molecular Modeling Market, By Tools, 2018-2028 (USD Billion)

49. South Africa Structural Biology and Molecular Modeling Market, By Application, 2018-2028 (USD Billion)

List of Figures 

1. Global Structural Biology and Molecular Modeling Market Segmentation

2. Structural Biology and Molecular Modeling Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Structural Biology and Molecular Modeling Market Attractiveness Analysis By Tools

9. Global Structural Biology and Molecular Modeling Market Attractiveness Analysis By Application

10. Global Structural Biology and Molecular Modeling Market Attractiveness Analysis By Region

11. Global Structural Biology and Molecular Modeling Market: Dynamics

12. Global Structural Biology and Molecular Modeling Market Share by Tools(2021 &2028)

13. Global Structural Biology and Molecular Modeling Market Share by Application(2021 &2028)

14. Global Structural Biology and Molecular Modeling Market Share by Regions (2021 &2028)

15. Global Structural Biology and Molecular Modeling Market Share by Company (2020)

This study forecasts revenue at global, regional, and country levels from 2018 to 2028. The Brainy Insights has segmented the global Structural Biology and Molecular Modeling market on the basis of below mentioned segments:

Global Structural Biology and Molecular Modeling Market by Tools:

  • SaaS& standalone modeling
    •   Homology modeling
    •   Threading
    •   Molecular dynamics
    • Ab Initio
    •   Hybrid
    •   Others
  • Visualization & analysis
  • Databases
  • Others

Global Structural Biology and Molecular Modeling Market by Application:

  • Drug development
  • Drug discovery
  • Others

Global Structural Biology and Molecular Modeling Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • >South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date